161: $148,000,000
#SistersInLaw
Review of FDA Approval and Standing to Bring the Case
This chapter discusses the review of a court decision regarding the FDA approval of a drug, Miffer-Pristone, and the standing of a group of doctors who oppose the approval. The chapter explores the potential impact of the case on the administrative state and the nationwide availability of abortion.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
